Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females 2 years and older~* Has a clinical diagnosis of AD according to the criteria of Hanifin and Rajka~* Has AD involvement ≥ 5% Treatable %BSA (excluding the scalp)~* Has an ISGA score of Mild (2) or Moderate (3) at Baseline/Day 1~* All female subjects of childbearing potential must use acceptable methods of contraception from the Screening Visit continuously until 30 days after stopping study drug~Exclusion Criteria:~* As determined by the study doctor, a medical history that may interfere with study objectives~* Unstable AD or any consistent requirement for high potency topical corticosteroids~* History of use of biologic therapy (including intravenous immunoglobulin)~* Recent or anticipated concomitant use of systemic or topical therapies that might alter the course of AD~* Recent or current participation in another research study~* Females who are breastfeeding, pregnant, or with plans to get pregnant during the participation in the study~* Participation in a previous AN2728 clinical trial

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AN2728 Topical Ointment, 2% (Type: EXPERIMENTAL): AN2728 Topical Ointment, 2%, applied twice daily for up to 28 days
- Matching vehicle control (Type: PLACEBO_COMPARATOR): Matching vehicle control, applied twice daily for up to 28 days

Based on this trial design, predict the completion outcome and termination type (if applicable).